Companies: 10,795·Total market cap: $144.5T
Obalon Therapeutics, Inc.

Obalon Therapeutics, Inc.

OBLNNASDAQHealthcare
$3.05
$-0.19(-5.86%)
Market Cap$5472310
P/E Ratio
52W High$4.8
52W Low$2.948
Overview

Obalon Therapeutics, Inc. (OBLN) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

obln · stock forecast · 6 analysts (3M) · FMP

Analyst Rating & Consensus

Based on 6 Wall Street analysts in the past 3 months

SellBuy

Hold

6 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
2
Hold
4
Sell
0
Strong Sell
0
Total: 6 · Buy rate: 33.3%

12-Month Price Target

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $3.05

The Obalon Therapeutics, Inc. (OBLN) analyst consensus is Hold, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month OBLN price target is $0.00, representing +0.0% upside from the current price of $3.05.

Short-Term Price Prediction

Short-term price predictions will be available once the prediction engine is ready.

Long-Term Stock Price Prediction

Long-term price predictions will be available once the prediction engine is ready.

Stock Forecast Based on Technical Analysis

Technical analysis will be available once the prediction engine is ready.

Latest Analyst Ratings & Upgrades

Filter:

Wall Street analysts have recently issued updated ratings on Obalon Therapeutics, Inc. (OBLN) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 6 analysts currently cover OBLN.

Analyst Recommendation Trends

OBLN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

Revenue Next Year

EPS This Year

EPS Next Year

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast OBLN EPS of $ for the current fiscal year, based on estimates from 0 analysts. The OBLN revenue forecast is for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The OBLN stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus OBLN price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.

Obalon Therapeutics, Inc. trades on NASDAQ under the ticker OBLN. The OBLN stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 33% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

OBLN forecast · 8 questions

According to 6 Wall Street analysts, the average 12-month OBLN price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $3.05.

OBLN price targetWhat is OBLN price targetOBLN analyst price targetOBLN 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.